Smartleaf Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.6M Buy
8,751
+1,588
+22% +$472K 0.09% 191
2025
Q4
$1.98M Buy
7,163
+592
+9% +$161K 0.07% 234
2025
Q3
$1.79M Buy
6,571
+1,909
+41% +$519K 0.11% 208
2025
Q2
$1.28M Buy
4,662
+178
+4% +$48.4K 0.11% 204
2025
Q1
$1.18M Buy
4,484
+580
+15% +$143K 0.11% 204
2024
Q4
$904K Buy
3,904
+685
+21% +$158K 0.09% 235
2024
Q3
$703K Buy
3,219
+882
+38% +$183K 0.09% 250
2024
Q2
$457K Buy
2,337
+398
+21% +$82.2K 0.07% 253
2024
Q1
$418K Buy
1,939
+558
+40% +$117K 0.08% 240
2023
Q4
$290K Buy
+1,381
New +$295K 0.08% 253

Other funds holding CME

Smartleaf Asset Management's CME Position: Q1 2026 in Review

Smartleaf Asset Management increased its CME Group (CME) stake by 22% in Q1 2026, buying an estimated $472K and bringing the position to 8,751 shares worth $2.6M. The position accounts for 0.09% of the portfolio, ranked #191.

Smartleaf Asset Management first reported a position in CME in Q4 2023 and has held it in 10 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Smartleaf Asset Management held 8,751 shares of CME Group worth $2.6M as of Q1 2026.
  • Smartleaf Asset Management bought 1,588 CME Group shares in Q1 2026, an estimated $472K.
  • CME Group made up 0.09% of Smartleaf Asset Management's portfolio in Q1 2026, its #191 holding.
  • Smartleaf Asset Management first reported a position in CME Group in Q4 2023 and has held it in 10 quarters since.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.